Used in all age groups hypertension including ACE inhibitor intolerant patients.
Better BP control than ramipril & valsartan in last hrs of the dosing interval
Modulates PPAR, thus reducing insulin resistance and metabolic syndrome.
Unique protective properties against target end-organ damage.
Offers clinically and scientifically effective BP reduction across 24 hrs.
Blocks the vasoconstrictor and aldosterone-secretion effects of angiotensin II enzyme.
Exhibits fast distribution in most tissues.
Reduces arterial blood pressure.
First choice for treating primary arterial hypertension.
© 2019 QLife Pharma All rights reserved. Powered by 
